Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J7GF
|
||||
Former ID |
DNC011964
|
||||
Drug Name |
Benzyl-(2-phenyl-quinazolin-4-yl)-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [533684] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H17N3
|
||||
Canonical SMILES |
C1=CC=C(C=C1)CNC2=NC(=NC3=CC=CC=C32)C4=CC=CC=C4
|
||||
InChI |
1S/C21H17N3/c1-3-9-16(10-4-1)15-22-21-18-13-7-8-14-19(18)23-20(24-21)17-11-5-2-6-12-17/h1-14H,15H2,(H,22,23,24)
|
||||
InChIKey |
WXCHSHPXEPXKFN-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | CAMP-specific 3',5'-cyclic phosphodiesterase 4B | Target Info | Inhibitor | [533684] | |
Sodium-dependent dopamine transporter | Target Info | Inhibitor | [535513] | ||
CAMP-specific 3',5'-cyclic phosphodiesterase 4A | Target Info | Inhibitor | [533684] | ||
NetPath Pathway | IL5 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
Pathway Interaction Database | Alpha-synuclein signaling | ||||
WikiPathways | G Protein Signaling Pathways | ||||
Myometrial Relaxation and Contraction Pathways | |||||
Nuclear Receptors Meta-Pathway | |||||
Opioid SignallingWP727:Monoamine Transport | |||||
NRF2 pathway | |||||
Dopaminergic Neurogenesis | |||||
Parkinsons Disease Pathway | |||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||||
Neurotransmitter Clearance In The Synaptic CleftWP35:G Protein Signaling Pathways | |||||
References | |||||
Ref 533684 | J Med Chem. 1995 Sep 1;38(18):3547-57.Discovery of potent cyclic GMP phosphodiesterase inhibitors. 2-Pyridyl- and 2-imidazolylquinazolines possessing cyclic GMP phosphodiesterase and thromboxane synthesis inhibitory activities. | ||||
Ref 535513 | Identification of a novel partial inhibitor of dopamine transporter among 4-substituted 2-phenylquinazolines. Bioorg Med Chem Lett. 2002 Aug 19;12(16):2225-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.